APO Research
Talk to an analyst

APO RESEARCH · REPORT

Implantable Drug Eluting Balloon

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Implantable Drug Eluting Balloon Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025184 pages

Choose your research edition.

Industry ResearchImplantable Drug Eluting Balloon Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Implantable Drug Eluting Balloon Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Implantable Drug Eluting Balloon Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Implantable Drug Eluting Balloon Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Implantable Drug Eluting Balloon Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Implantable Drug Eluting Balloon market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Implantable Drug Eluting Balloon is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Implantable Drug Eluting Balloon is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Implantable Drug Eluting Balloon is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Implantable Drug Eluting Balloon is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Implantable Drug Eluting Balloon include Yinyi Biotech, Medtronic, Philips, Boston Scientific, B. Braun, Eurocor, BD, Aachen Resonance and Biotronic, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Implantable Drug Eluting Balloon market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Implantable Drug Eluting Balloon and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Implantable Drug Eluting Balloon sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Implantable Drug Eluting Balloon market size, projected growth trends, production technologies, key applications, and end-use industries.

Implantable Drug Eluting Balloon Segment by Company

Yinyi Biotech

Medtronic

Philips

Boston Scientific

B. Braun

Eurocor

BD

Aachen Resonance

Biotronic

Implantable Drug Eluting Balloon Segment by Type

Peripheral DEBs

Coronary DEBs

Implantable Drug Eluting Balloon Segment by Application

Catheterization Laboratory

Hospital

Other

Implantable Drug Eluting Balloon Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Implantable Drug Eluting Balloon market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Implantable Drug Eluting Balloon and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Implantable Drug Eluting Balloon.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Implantable Drug Eluting Balloon market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Implantable Drug Eluting Balloon manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Implantable Drug Eluting Balloon in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Implantable Drug Eluting Balloon in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Implantable Drug Eluting Balloon Industry Trends Table 2. Implantable Drug Eluting Balloon Industry Drivers Table 3. Implantable Drug Eluting Balloon Industry Opportunities and Challenges Table 4. Implantable Drug Eluting Balloon Industry Restraints Table 5. Global Implantable Drug Eluting Balloon Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Implantable Drug Eluting Balloon Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Implantable Drug Eluting Balloon Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Implantable Drug Eluting Balloon Sales Market Share by Manufacturers Table 9. Global Implantable Drug Eluting Balloon Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Implantable Drug Eluting Balloon Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Implantable Drug Eluting Balloon Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Implantable Drug Eluting Balloon Manufacturers, Product Type & Application Table 13. Global Implantable Drug Eluting Balloon Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Implantable Drug Eluting Balloon by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Peripheral DEBs Table 17. Major Manufacturers of Coronary DEBs Table 18. Global Implantable Drug Eluting Balloon Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Implantable Drug Eluting Balloon Sales by Type (2021-2026) & (K Units) Table 20. Global Implantable Drug Eluting Balloon Sales by Type (2027-2032) & (K Units) Table 21. Global Implantable Drug Eluting Balloon Sales Market Share by Type (2021-2026) Table 22. Global Implantable Drug Eluting Balloon Sales Market Share by Type (2027-2032) Table 23. Global Implantable Drug Eluting Balloon Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Implantable Drug Eluting Balloon Revenue by Type (2021-2026) & (K Units) Table 25. Global Implantable Drug Eluting Balloon Revenue by Type (2027-2032) & (K Units) Table 26. Global Implantable Drug Eluting Balloon Revenue Market Share by Type (2021-2026) Table 27. Global Implantable Drug Eluting Balloon Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Catheterization Laboratory Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Other Table 31. Global Implantable Drug Eluting Balloon Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Implantable Drug Eluting Balloon Sales by Application (2021-2026) & (K Units) Table 33. Global Implantable Drug Eluting Balloon Sales by Application (2027-2032) & (K Units) Table 34. Global Implantable Drug Eluting Balloon Sales Market Share by Application (2021-2026) Table 35. Global Implantable Drug Eluting Balloon Sales Market Share by Application (2027-2032) Table 36. Global Implantable Drug Eluting Balloon Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Implantable Drug Eluting Balloon Revenue by Application (2021-2026) & (K Units) Table 38. Global Implantable Drug Eluting Balloon Revenue by Application (2027-2032) & (K Units) Table 39. Global Implantable Drug Eluting Balloon Revenue Market Share by Application (2021-2026) Table 40. Global Implantable Drug Eluting Balloon Revenue Market Share by Application (2027-2032) Table 41. Global Implantable Drug Eluting Balloon Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Implantable Drug Eluting Balloon Sales by Region (2021-2026) & (K Units) Table 43. Global Implantable Drug Eluting Balloon Sales Market Share by Region (2021-2026) Table 44. Global Implantable Drug Eluting Balloon Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Implantable Drug Eluting Balloon Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Implantable Drug Eluting Balloon Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Implantable Drug Eluting Balloon Sales by Country (2021-2026) & (K Units) Table 48. North America Implantable Drug Eluting Balloon Sales by Country (2027-2032) & (K Units) Table 49. Europe Implantable Drug Eluting Balloon Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Implantable Drug Eluting Balloon Sales by Country (2021-2026) & (K Units) Table 51. Europe Implantable Drug Eluting Balloon Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Implantable Drug Eluting Balloon Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Implantable Drug Eluting Balloon Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Implantable Drug Eluting Balloon Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Implantable Drug Eluting Balloon Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Implantable Drug Eluting Balloon Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Implantable Drug Eluting Balloon Sales by Country (2027-2032) & (K Units) Table 58. Global Implantable Drug Eluting Balloon Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Implantable Drug Eluting Balloon Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Implantable Drug Eluting Balloon Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Implantable Drug Eluting Balloon Revenue Market Share by Region (2021-2026) Table 62. Global Implantable Drug Eluting Balloon Revenue Market Share by Region (2027-2032) Table 63. Yinyi Biotech Company Information Table 64. Yinyi Biotech Business Overview Table 65. Yinyi Biotech Implantable Drug Eluting Balloon Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Yinyi Biotech Implantable Drug Eluting Balloon Product Portfolio Table 67. Yinyi Biotech Recent Development Table 68. Medtronic Company Information Table 69. Medtronic Business Overview Table 70. Medtronic Implantable Drug Eluting Balloon Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Medtronic Implantable Drug Eluting Balloon Product Portfolio Table 72. Medtronic Recent Development Table 73. Philips Company Information Table 74. Philips Business Overview Table 75. Philips Implantable Drug Eluting Balloon Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Philips Implantable Drug Eluting Balloon Product Portfolio Table 77. Philips Recent Development Table 78. Boston Scientific Company Information Table 79. Boston Scientific Business Overview Table 80. Boston Scientific Implantable Drug Eluting Balloon Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Boston Scientific Implantable Drug Eluting Balloon Product Portfolio Table 82. Boston Scientific Recent Development Table 83. B. Braun Company Information Table 84. B. Braun Business Overview Table 85. B. Braun Implantable Drug Eluting Balloon Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. B. Braun Implantable Drug Eluting Balloon Product Portfolio Table 87. B. Braun Recent Development Table 88. Eurocor Company Information Table 89. Eurocor Business Overview Table 90. Eurocor Implantable Drug Eluting Balloon Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Eurocor Implantable Drug Eluting Balloon Product Portfolio Table 92. Eurocor Recent Development Table 93. BD Company Information Table 94. BD Business Overview Table 95. BD Implantable Drug Eluting Balloon Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. BD Implantable Drug Eluting Balloon Product Portfolio Table 97. BD Recent Development Table 98. Aachen Resonance Company Information Table 99. Aachen Resonance Business Overview Table 100. Aachen Resonance Implantable Drug Eluting Balloon Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Aachen Resonance Implantable Drug Eluting Balloon Product Portfolio Table 102. Aachen Resonance Recent Development Table 103. Biotronic Company Information Table 104. Biotronic Business Overview Table 105. Biotronic Implantable Drug Eluting Balloon Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Biotronic Implantable Drug Eluting Balloon Product Portfolio Table 107. Biotronic Recent Development Table 108. Key Raw Materials Table 109. Raw Materials Key Suppliers Table 110. Implantable Drug Eluting Balloon Distributors List Table 111. Implantable Drug Eluting Balloon Customers List Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Implantable Drug Eluting Balloon Product Image Figure 2. Global Implantable Drug Eluting Balloon Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Implantable Drug Eluting Balloon Market Size (2021-2032) & (US$ Million) Figure 4. Global Implantable Drug Eluting Balloon Sales (2021-2032) & (K Units) Figure 5. Global Implantable Drug Eluting Balloon Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Implantable Drug Eluting Balloon Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Peripheral DEBs Image Figure 9. Coronary DEBs Image Figure 10. Global Implantable Drug Eluting Balloon Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Implantable Drug Eluting Balloon Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Implantable Drug Eluting Balloon Sales Market Share by Type (2021-2032) Figure 13. Global Implantable Drug Eluting Balloon Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Implantable Drug Eluting Balloon Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Implantable Drug Eluting Balloon Revenue Market Share by Type (2021-2032) Figure 16. Catheterization Laboratory Image Figure 17. Hospital Image Figure 18. Other Image Figure 19. Global Implantable Drug Eluting Balloon Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Implantable Drug Eluting Balloon Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Implantable Drug Eluting Balloon Sales Market Share by Application (2021-2032) Figure 22. Global Implantable Drug Eluting Balloon Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Implantable Drug Eluting Balloon Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Implantable Drug Eluting Balloon Revenue Market Share by Application (2021-2032) Figure 25. North America Implantable Drug Eluting Balloon Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Implantable Drug Eluting Balloon Sales Market Share by Country (2021-2032) Figure 27. U.S. Implantable Drug Eluting Balloon Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Implantable Drug Eluting Balloon Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Implantable Drug Eluting Balloon Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Implantable Drug Eluting Balloon Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Implantable Drug Eluting Balloon Sales Market Share by Country (2021-2032) Figure 32. Germany Implantable Drug Eluting Balloon Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Implantable Drug Eluting Balloon Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Implantable Drug Eluting Balloon Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Implantable Drug Eluting Balloon Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Implantable Drug Eluting Balloon Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Implantable Drug Eluting Balloon Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Implantable Drug Eluting Balloon Sales Market Share by Country (2021-2032) Figure 39. China Implantable Drug Eluting Balloon Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Implantable Drug Eluting Balloon Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Implantable Drug Eluting Balloon Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Implantable Drug Eluting Balloon Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Implantable Drug Eluting Balloon Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Implantable Drug Eluting Balloon Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Implantable Drug Eluting Balloon Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Implantable Drug Eluting Balloon Sales Market Share by Country (2021-2032) Figure 47. Brazil Implantable Drug Eluting Balloon Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Implantable Drug Eluting Balloon Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Implantable Drug Eluting Balloon Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Implantable Drug Eluting Balloon Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Implantable Drug Eluting Balloon Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Implantable Drug Eluting Balloon Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Implantable Drug Eluting Balloon Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Implantable Drug Eluting Balloon Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Implantable Drug Eluting Balloon Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Implantable Drug Eluting Balloon Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Implantable Drug Eluting Balloon Revenue (2021-2032) & (US$ Million) Figure 58. North America Implantable Drug Eluting Balloon Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Implantable Drug Eluting Balloon Revenue (2021-2032) & (US$ Million) Figure 60. Europe Implantable Drug Eluting Balloon Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Implantable Drug Eluting Balloon Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Implantable Drug Eluting Balloon Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Implantable Drug Eluting Balloon Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Implantable Drug Eluting Balloon Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Implantable Drug Eluting Balloon Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Implantable Drug Eluting Balloon Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Peripheral DEBs
  • Coronary DEBs
Applications
  • Catheterization Laboratory
  • Hospital
  • Other
Companies covered
  • Yinyi Biotech
  • Medtronic
  • Philips
  • Boston Scientific
  • B. Braun
  • Eurocor
  • BD
  • Aachen Resonance
  • Biotronic

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Implantable Drug Eluting Balloon Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Implantable Drug Eluting Balloon Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Implantable Drug Eluting Balloon Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Implantable Drug Eluting Balloon Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Implantable Drug Eluting Balloon Market Dynamics
  1. 2.1 Implantable Drug Eluting Balloon Industry Trends
  2. 2.2 Implantable Drug Eluting Balloon Industry Drivers
  3. 2.3 Implantable Drug Eluting Balloon Industry Opportunities and Challenges
  4. 2.4 Implantable Drug Eluting Balloon Industry Restraints
3 Implantable Drug Eluting Balloon Market by Manufacturers
  1. 3.1 Global Implantable Drug Eluting Balloon Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Implantable Drug Eluting Balloon Sales by Manufacturers (2021-2026)
  3. 3.3 Global Implantable Drug Eluting Balloon Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Implantable Drug Eluting Balloon Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Implantable Drug Eluting Balloon Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Implantable Drug Eluting Balloon Manufacturers, Product Type & Application
  7. 3.7 Global Implantable Drug Eluting Balloon Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Implantable Drug Eluting Balloon Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Implantable Drug Eluting Balloon Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Implantable Drug Eluting Balloon Tier 1, Tier 2, and Tier 3
4 Implantable Drug Eluting Balloon Market by Type
  1. 4.1 Implantable Drug Eluting Balloon Type Introduction
  2. 4.1.1 Peripheral DEBs
  3. 4.1.2 Coronary DEBs
  4. 4.2 Global Implantable Drug Eluting Balloon Sales by Type
  5. 4.2.1 Global Implantable Drug Eluting Balloon Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Implantable Drug Eluting Balloon Sales by Type (2021-2032)
  7. 4.2.3 Global Implantable Drug Eluting Balloon Sales Market Share by Type (2021-2032)
  8. 4.3 Global Implantable Drug Eluting Balloon Revenue by Type
  9. 4.3.1 Global Implantable Drug Eluting Balloon Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Implantable Drug Eluting Balloon Revenue by Type (2021-2032)
  11. 4.3.3 Global Implantable Drug Eluting Balloon Revenue Market Share by Type (2021-2032)
5 Implantable Drug Eluting Balloon Market by Application
  1. 5.1 Implantable Drug Eluting Balloon Application Introduction
  2. 5.1.1 Catheterization Laboratory
  3. 5.1.2 Hospital
  4. 5.1.3 Other
  5. 5.2 Global Implantable Drug Eluting Balloon Sales by Application
  6. 5.2.1 Global Implantable Drug Eluting Balloon Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Implantable Drug Eluting Balloon Sales by Application (2021-2032)
  8. 5.2.3 Global Implantable Drug Eluting Balloon Sales Market Share by Application (2021-2032)
  9. 5.3 Global Implantable Drug Eluting Balloon Revenue by Application
  10. 5.3.1 Global Implantable Drug Eluting Balloon Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Implantable Drug Eluting Balloon Revenue by Application (2021-2032)
  12. 5.3.3 Global Implantable Drug Eluting Balloon Revenue Market Share by Application (2021-2032)
6 Global Implantable Drug Eluting Balloon Sales by Region
  1. 6.1 Global Implantable Drug Eluting Balloon Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Implantable Drug Eluting Balloon Sales by Region (2021-2032)
  3. 6.2.1 Global Implantable Drug Eluting Balloon Sales by Region (2021-2026)
  4. 6.2.2 Global Implantable Drug Eluting Balloon Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Implantable Drug Eluting Balloon Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Implantable Drug Eluting Balloon Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Implantable Drug Eluting Balloon Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Implantable Drug Eluting Balloon Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Implantable Drug Eluting Balloon Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Implantable Drug Eluting Balloon Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Implantable Drug Eluting Balloon Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Implantable Drug Eluting Balloon Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Implantable Drug Eluting Balloon Revenue by Region
  1. 7.1 Global Implantable Drug Eluting Balloon Revenue by Region
  2. 7.1.1 Global Implantable Drug Eluting Balloon Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Implantable Drug Eluting Balloon Revenue by Region (2021-2026)
  4. 7.1.3 Global Implantable Drug Eluting Balloon Revenue by Region (2027-2032)
  5. 7.1.4 Global Implantable Drug Eluting Balloon Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Implantable Drug Eluting Balloon Revenue (2021-2032)
  8. 7.2.2 North America Implantable Drug Eluting Balloon Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Implantable Drug Eluting Balloon Revenue (2021-2032)
  11. 7.3.2 Europe Implantable Drug Eluting Balloon Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Implantable Drug Eluting Balloon Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Implantable Drug Eluting Balloon Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Implantable Drug Eluting Balloon Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Implantable Drug Eluting Balloon Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Yinyi Biotech
  2. 8.1.1 Yinyi Biotech Company Information
  3. 8.1.2 Yinyi Biotech Business Overview
  4. 8.1.3 Yinyi Biotech Implantable Drug Eluting Balloon Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Yinyi Biotech Implantable Drug Eluting Balloon Product Portfolio
  6. 8.1.5 Yinyi Biotech Recent Developments
  7. 8.2 Medtronic
  8. 8.2.1 Medtronic Company Information
  9. 8.2.2 Medtronic Business Overview
  10. 8.2.3 Medtronic Implantable Drug Eluting Balloon Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Medtronic Implantable Drug Eluting Balloon Product Portfolio
  12. 8.2.5 Medtronic Recent Developments
  13. 8.3 Philips
  14. 8.3.1 Philips Company Information
  15. 8.3.2 Philips Business Overview
  16. 8.3.3 Philips Implantable Drug Eluting Balloon Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Philips Implantable Drug Eluting Balloon Product Portfolio
  18. 8.3.5 Philips Recent Developments
  19. 8.4 Boston Scientific
  20. 8.4.1 Boston Scientific Company Information
  21. 8.4.2 Boston Scientific Business Overview
  22. 8.4.3 Boston Scientific Implantable Drug Eluting Balloon Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Boston Scientific Implantable Drug Eluting Balloon Product Portfolio
  24. 8.4.5 Boston Scientific Recent Developments
  25. 8.5 B. Braun
  26. 8.5.1 B. Braun Company Information
  27. 8.5.2 B. Braun Business Overview
  28. 8.5.3 B. Braun Implantable Drug Eluting Balloon Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 B. Braun Implantable Drug Eluting Balloon Product Portfolio
  30. 8.5.5 B. Braun Recent Developments
  31. 8.6 Eurocor
  32. 8.6.1 Eurocor Company Information
  33. 8.6.2 Eurocor Business Overview
  34. 8.6.3 Eurocor Implantable Drug Eluting Balloon Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Eurocor Implantable Drug Eluting Balloon Product Portfolio
  36. 8.6.5 Eurocor Recent Developments
  37. 8.7 BD
  38. 8.7.1 BD Company Information
  39. 8.7.2 BD Business Overview
  40. 8.7.3 BD Implantable Drug Eluting Balloon Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 BD Implantable Drug Eluting Balloon Product Portfolio
  42. 8.7.5 BD Recent Developments
  43. 8.8 Aachen Resonance
  44. 8.8.1 Aachen Resonance Company Information
  45. 8.8.2 Aachen Resonance Business Overview
  46. 8.8.3 Aachen Resonance Implantable Drug Eluting Balloon Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Aachen Resonance Implantable Drug Eluting Balloon Product Portfolio
  48. 8.8.5 Aachen Resonance Recent Developments
  49. 8.9 Biotronic
  50. 8.9.1 Biotronic Company Information
  51. 8.9.2 Biotronic Business Overview
  52. 8.9.3 Biotronic Implantable Drug Eluting Balloon Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Biotronic Implantable Drug Eluting Balloon Product Portfolio
  54. 8.9.5 Biotronic Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Implantable Drug Eluting Balloon Value Chain Analysis
  2. 9.1.1 Implantable Drug Eluting Balloon Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Implantable Drug Eluting Balloon Production Mode & Process
  6. 9.2 Implantable Drug Eluting Balloon Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Implantable Drug Eluting Balloon Distributors
  9. 9.2.3 Implantable Drug Eluting Balloon Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst